Luciana J El-Kadre1, Augusto C A Tinoco. 1. Center for Surgical Treatment of Obesity and Type 2 Diabetes. São José do Avaí Hospital. Itaperuna, Rio de Janeiro, Brazil. el-kadre@uol.com.br
Abstract
PURPOSE OF REVIEW: The concept of IL-6 as a deleterious interleukin was challenged by its anti-inflammatory actions. RECENT FINDINGS: The beneficial health effects of exercise and the crosstalk between insulin-sensitive tissues and insulin-producing cells are mediated by IL-6. SUMMARY: IL-6 displays pleiotropic functions in a tissue-specific and physiological context-dependent manner. There is evidence suggesting that IL-6 worsens insulin resistance in the liver and adipose tissue, while improving insulin sensitivity in the muscle. The effects of this cytokine are influenced by its acute or chronical presence, the latter being associated with insulin resistance. IL-6 has anti-inflammatory effects and a compensatory role in obesity by increasing islet GLP-1 production. The therapeutic approach of blocking IL-6 signal can be diabetogenic.
PURPOSE OF REVIEW: The concept of IL-6 as a deleterious interleukin was challenged by its anti-inflammatory actions. RECENT FINDINGS: The beneficial health effects of exercise and the crosstalk between insulin-sensitive tissues and insulin-producing cells are mediated by IL-6. SUMMARY:IL-6 displays pleiotropic functions in a tissue-specific and physiological context-dependent manner. There is evidence suggesting that IL-6 worsens insulin resistance in the liver and adipose tissue, while improving insulin sensitivity in the muscle. The effects of this cytokine are influenced by its acute or chronical presence, the latter being associated with insulin resistance. IL-6 has anti-inflammatory effects and a compensatory role in obesity by increasing islet GLP-1 production. The therapeutic approach of blocking IL-6 signal can be diabetogenic.
Authors: Hiba AbouAssi; K Noelle Tune; Brian Gilmore; Lori A Bateman; Gary McDaniel; Michael Muehlbauer; Janet L Huebner; Helen M Hoenig; Virginia B Kraus; E William St Clair; William E Kraus; Kim M Huffman Journal: J Rheumatol Date: 2014-07-01 Impact factor: 4.666
Authors: Maria Alice Freitas Queiroz; Pablo Fabiano Moura das Neves; Sandra Souza Lima; Jeferson da Costa Lopes; Maria Karoliny da Silva Torres; Izaura Maria Vieira Cayres Vallinoto; Carlos David Araújo Bichara; Erika Ferreira Dos Santos; Mioni Thieli Figueiredo Magalhães de Brito; Andréa Luciana Soares da Silva; Mauro de Meira Leite; Flávia Póvoa da Costa; Maria de Nazaré do Socorro de Almeida Viana; Fabíola Brasil Barbosa Rodrigues; Kevin Matheus Lima de Sarges; Marcos Henrique Damasceno Cantanhede; Rosilene da Silva; Clea Nazaré Carneiro Bichara; Ana Virgínia Soares van den Berg; Adriana de Oliveira Lameira Veríssimo; Mayara da Silva Carvalho; Daniele Freitas Henriques; Carla Pinheiro Dos Santos; Juliana Abreu Lima Nunes; Iran Barros Costa; Giselle Maria Rachid Viana; Francisca Regina Oliveira Carneiro; Vera Regina da Cunha Menezes Palacios; Juarez Antonio Simões Quaresma; Igor Brasil-Costa; Eduardo José Melo Dos Santos; Luiz Fábio Magno Falcão; Antonio Carlos Rosário Vallinoto Journal: Front Cell Infect Microbiol Date: 2022-06-30 Impact factor: 6.073
Authors: I La Fratta; R Tatangelo; G Campagna; A Rizzuto; S Franceschelli; A Ferrone; A Patruno; L Speranza; M A De Lutiis; M Felaco; A Grilli; M Pesce Journal: Sci Rep Date: 2018-02-14 Impact factor: 4.379
Authors: Katarzyna Siewko; Rafal Maciulewski; Anna Zielinska-Maciulewska; Anna Poplawska-Kita; Piotr Szumowski; Natalia Wawrusiewicz-Kurylonek; Danuta Lipinska; Robert Milewski; Maria Gorska; Adam Kretowski; Malgorzata Szelachowska Journal: Biomed Res Int Date: 2019-10-20 Impact factor: 3.411